The World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD) marked 60 years of being the global centre of expertise in the diagnostics and surveillance of foot-and-mouth disease (FMD) with a two-day symposium on Monday 5 and Tuesday 6 November. The Pirbright Institute, home to the WRLFMD, welcomed visitors from across the globe for a series of talks that showcased the WLRFMD’s contribution to science and its commitment to protect the world’s livestock from foot-and-mouth disease (FMD).
Dr Donald King, Head of the WRLFMD said: “The symposium was a fantastic opportunity for us to celebrate the WRLFMD’s many great achievements, and to thank those that have joined us in the global fight against FMD, both past and present.”
Pirbright was designated as the WRLFMD by the Food and Agriculture Organisation of the United Nations (FAO) in 1958. Over the past 60 years, the WRLFMD has played a leading role in coordinating international networks that improve laboratory diagnostic capacity and undertake global surveillance for FMD.
The WRLFMD is at the forefront of developing methods for the detection of FMD, including ELISA diagnostic tests for FMD, molecular detection methods and pen-side tests for field diagnosis. Funding from Defra and the Biotechnology and Biological Sciences Research Council (BBSRC) continues to be essential to provide the expertise and innovation routinely applied by the WRLFMD.
Dr Bryan Charleston, Director of The Pirbright Institute, said: “Our world class facilities and scientists, coupled with our important international networks provides a unique hub for collaborative research that we hope one day will enable our ultimate goal of FMD control to be realised.”
The synergy between fundamental and applied science was evident as prominent speakers reviewed the current activities of the WRLFMD (and associated Networks) and discussed new research opportunities to monitor, diagnose and control FMD by applying knowledge from fundamental research initiatives that aim to understand the pathogenesis, host responses and epidemiology of this important transboundary disease.
Christine Middlemiss, the UK’s Chief Veterinary Officer, said: “I was delighted and honoured to open the symposium celebrating 60 years of the WRLFMD at Pirbright. The reference laboratories provide an integral part of the UK’s defences against foot-and-mouth disease through surveillance, helping keep our UK livestock safe from a potentially economically devastating disease.”
Matthew Stone, Deputy Director General of the World Organisation for Animal Health (OIE) added: “The services provided by the WRLFMD are pivotal in the global campaign against FMD. The symposium highlighted how over the last 60 years the WRLFMD has contributed to improvements in our understanding of the global epidemiology of FMD, and control and prevention strategies for our member countries. The WRLFMD provides scientific leadership of the network of OIE and FAO Reference Laboratories, and has contributed to building international diagnostic capability through OIE laboratory twinning programmes.”
In the past, these activities have supported FMD control programmes in Europe that have led to the eradication of the disease from the continent. More recently, efforts have been focused at generating innovative approaches to reduce the burden of FMD in countries in Asia and Africa where the disease is endemic, and to quantify risks for onward spread to FMD-free countries.
Two researchers who helped tackle the major UK outbreaks in 1967 and 2001 made a special address to delegates at a symposium celebratory dinner – Emeritus Professor Dave Rowlands, who worked at the Institute for Animal Virus Research from 1964-1983 before joining Wellcome Biotech where he was part of the team that solved the structure of FMDV, and Dr Nick Knowles who joined the WRLFMD in 1971.
Follow the WRLFMD on Twitter
About The Pirbright Institute
The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. Based in the UK and receiving strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), the Institute works to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience.
With an annual income of nearly £32.1 million from grants and commercial activity, and a total of £14.3 million strategic investment from BBSRC during 2017-2018, the Institute contributes to global food security and health, improving quality of life for animals and people.
For more information about The Pirbright Institute see: www.pirbright.ac.uk
The Biotechnology and Biological Sciences Research Council (BBSRC) is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by government, BBSRC invested £498 million in world-class bioscience in 2017-18. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
More information about BBSRC, our science and our impact: www.bbsrc.ukri.org
More information about BBSRC strategically funded institutes